106 related articles for article (PubMed ID: 2188253)
1. Immunoreactive trypsin(ogen) in the sera of children with recent-onset insulin-dependent diabetes and matched controls. The Swedish Childhood Diabetes Group.
Landin-Olsson M; Borgström A; Blom L; Sundkvist G; Lernmark A
Pancreas; 1990 May; 5(3):241-7. PubMed ID: 2188253
[TBL] [Abstract][Full Text] [Related]
2. Plasma immunoreactive pancreatic cationic trypsinogen in cystic fibrosis: a sensitive indicator of exocrine pancreatic dysfunction.
Durie PR; Largman C; Brodrick JW; Johnson JH; Gaskin KJ; Forstner GG; Geokas MC
Pediatr Res; 1981 Oct; 15(10):1351-5. PubMed ID: 7301457
[TBL] [Abstract][Full Text] [Related]
3. Plasma immunoreactive cationic trypsin(ogen) pattern in reserpinized rat model of cystic fibrosis. Resemblance to humans.
Weizman Z
Dig Dis Sci; 1996 May; 41(5):853-8. PubMed ID: 8625754
[TBL] [Abstract][Full Text] [Related]
4. Exocrine pancreatic function (serum immunoreactive trypsin, fecal chymotrypsin, and pancreatic isoamylase) in Indian diabetics.
Yajnik CS; Sahasrabudhe RA; Naik SS; Katrak A; Shelgikar KM; Kanitkar SV; Narayanan VA; Dandona P
Pancreas; 1990 Nov; 5(6):631-8. PubMed ID: 2281079
[TBL] [Abstract][Full Text] [Related]
5. Plasma immunoreactive-trypsin(ogen) levels during development.
Levine JJ; Udall JN; Bloch KJ; Hanson DG; James BC; Walker WA
J Pediatr Gastroenterol Nutr; 1988; 7(3):406-10. PubMed ID: 3260281
[TBL] [Abstract][Full Text] [Related]
6. Serum immunoreactive cationic trypsinogen: a useful indicator of severe exocrine dysfunction in the paediatric patient without cystic fibrosis.
Moore DJ; Forstner GG; Largman C; Cleghorn GJ; Wong SS; Durie PR
Gut; 1986 Nov; 27(11):1362-8. PubMed ID: 3792918
[TBL] [Abstract][Full Text] [Related]
7. Trypsinogen is not activated during cardiac surgery with extracorporeal circulation.
Jönsson P; Borgström A; Steen S; Ohlsson K
Scand J Clin Lab Invest; 1995 Aug; 55(5):441-5. PubMed ID: 8545603
[TBL] [Abstract][Full Text] [Related]
8. Effects of food intake and cholecystokinin on plasma trypsinogen levels in dogs.
Reidelberger RD; O'Rourke M; Durie PR; Geokas MC; Largman C
Am J Physiol; 1984 May; 246(5 Pt 1):G543-9. PubMed ID: 6326612
[TBL] [Abstract][Full Text] [Related]
9. Marked increase of trypsin(ogen) in serum of linitis plastica (gastric cancer, borrmann 4) patients.
Ichikawa Y; Koshikawa N; Hasegawa S; Ishikawa T; Momiyama N; Kunizaki C; Takahashi M; Moriwaki Y; Akiyama H; Yamaoka H; Yanoma S; Tsuburaya A; Nagashima Y; Shimada H; Miyazaki K
Clin Cancer Res; 2000 Apr; 6(4):1385-8. PubMed ID: 10778967
[TBL] [Abstract][Full Text] [Related]
10. Serum immunoreactive trypsin concentrations in diabetic children.
Moffat A; Marks V; Gamble DR
J Clin Pathol; 1980 Sep; 33(9):871-5. PubMed ID: 7430401
[TBL] [Abstract][Full Text] [Related]
11. Plasma immunoreactive anionic pancreatic trypsin in cystic fibrosis.
Durie PR; Gaskin KJ; Geokas MC; O'Rourke M; Largman C
J Pediatr Gastroenterol Nutr; 1982; 1(3):337-43. PubMed ID: 7186046
[TBL] [Abstract][Full Text] [Related]
12. Oral trypsin-inhibitor-induced improvement of the exocrine and endocrine pancreatic functions in alloxan diabetic rats.
Ihse I; Lundquist I; Arnesjö B
Scand J Gastroenterol; 1976; 11(4):363-8. PubMed ID: 779003
[TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of trypsin-like immunoreactivity and pancreatic isoamylase in insulin dependent diabetic patients.
Moles KW; Kerr JI; Armstrong E; Hayes JR; Buchanan KD
Pancreas; 1988; 3(2):135-9. PubMed ID: 3375227
[TBL] [Abstract][Full Text] [Related]
14. Serum immunoreactive pancreatic lipase and cationic trypsinogen for the assessment of exocrine pancreatic function in older patients with cystic fibrosis.
Cleghorn G; Benjamin L; Corey M; Forstner G; Dati F; Durie P
Pediatrics; 1986 Mar; 77(3):301-6. PubMed ID: 3951910
[TBL] [Abstract][Full Text] [Related]
15. Exocrine Proteins Including Trypsin(ogen) as a Key Biomarker in Type 1 Diabetes.
Bakinowska L; Vartak T; Phuthego T; Taylor M; Chandler K; Jerram ST; Williams S; Feldmann M; Johnson DG; Patel KA; Williams AJK; Long AE; Leslie RD; Gillespie KM; ;
Diabetes Care; 2023 Apr; 46(4):714-721. PubMed ID: 36701208
[TBL] [Abstract][Full Text] [Related]
16. Serum immunoreactive trypsin concentrations in infectious and non-infectious illnesses and in juvenile diabetes.
Gamble DR; Moffatt A; Marks V
J Clin Pathol; 1979 Sep; 32(9):897-901. PubMed ID: 512051
[TBL] [Abstract][Full Text] [Related]
17. Hypotrypsinaemia in diabetes mellitus.
Adrian TE; Barnes AJ; Bloom SR
Clin Chim Acta; 1979 Oct; 97(2-3):213-6. PubMed ID: 385175
[TBL] [Abstract][Full Text] [Related]
18. Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency.
Durie PR; Forstner GG; Gaskin KJ; Moore DJ; Cleghorn GJ; Wong SS; Corey ML
Pediatr Res; 1986 Mar; 20(3):209-13. PubMed ID: 3703609
[TBL] [Abstract][Full Text] [Related]
19. [Trypsin deficiency in diabetes mellitus of children and adolescents (author's transl)].
Sitzmann FC; Biro G; Dockter G
Klin Padiatr; 1981 Sep; 193(5):362-4. PubMed ID: 7289427
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum levels of immunoreactive anionic trypsin (but not cationic trypsin) signals pancreatic disease.
Borgström A; Andrén-Sandberg A
Int J Pancreatol; 1995 Dec; 18(3):221-5. PubMed ID: 8708393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
